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Towards a Better Management of Descending Aortic Dissection:
The Importance of Close Ambulatory Follow-up
R. Fattori*
Department of Radiology, Cardiovascular Unit, University Hospital S. Orsola, Bologna, ItalyOptimal management of patients with type B dissec-
tion is controversial. With modern aggressive medical
therapy and early endovascular repair for compli-
cated cases, up to 85e90% of patients survive the
acute phase.1 Nevertheless little progress has been
achieved in improving long-term prognosis. In the
current literature, information about long-term his-
tory is limited and variable, with survival rates rang-
ing from 56% to 92% at 1 year and from 48% to 80%
at 5 years. One of the largest retrospective analyses,
36-years outcome of type B dissection with 189
patients,2 showed actuarial survival estimates for the
medical patients of 85, 71, 38, and 20% at 1, 5, 10,
and 15 years respectively. The study of Winnerkvist
and colleagues3 reported a better outcome: 66
patients who survived an acute aortic syndrome,
including type B dissection, intramural haematoma
and penetrating ulcer, were followed for a mean of
79 months: survival at 1e5 and 10 years was 100%,
82% and 69% respectively. All 66 patients were sub-
mitted to regular follow-up with imaging studies
and referred for surgery or endovascular intervention
in case of complications or false lumen expansion
exceeding 6 cm. An initial diameter >4 cm and
intramural haematoma with localized dissection/
ulcer-like projection were significant predictor of new
morbidity during follow-up. The overall mean annual
change in aortic diameter was 1 2.4 mm/year, sig-
nificantly less than in previous studies.4 In particular,
patients with complete thrombosis of the false lumen
showed a progressive reduction of the aortic diameter
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though a high number (80%) of patients were free
from aortic events at 10 years, the remainder (20%)
escaped this careful monitoring and suffered aortic
related complications such as aneurysm rupture or
new dissection, in some cases despite normal aortic
diameters. This underscores the unpredictability of
the disease. Importantly, a high percentage of patients
(7.5%) developed an acute type A dissection during
follow-up. This complication also has been reported
after endovascular repair of type B dissection, raising
alarm signals regarding the safety of the current de-
vices. Again it is important to emphasise that, unfor-
tunately, extension of dissection may not be a specific
complication of stent-graft treatment, but may be
the sobering expression of the inexorable disease
continuum.
The study of Winnerkvist pointed out how an
aggressive medical management and follow-up sur-
veillance are crucial for improving outcome following
acute dissection. On the other hand, it becomes evi-
dent that the natural history and the long-term prog-
nosis might be distinctive for various subtypes of
dissection. Parameters other than the Laplace law
may affect aortic wall in dissection and aneurysm and
aortic rupture may occur without dilation, as reported
in the present study. Although tailored antihyperten-
sive therapy is effective for reduction of aneurysm
growth rate, there is a need to evaluate other thera-
peutic options and novel pharmacologic paradigms.
Advanced imaging modalities may offer potential im-
plements to recognize predictors of poor outcomes
both in the hospital and during the follow-up period,
such as abnormal elastic properties or inflammatory
markers as primary manifestation of aortic wall alter-
ation.5 Endovascular repair has been consideredrved.
357Towards a Better Management of Descending Aortic Dissectiona milestone6 in the history of management of type B
dissection. In comparison to open surgery, positive
results have been achieved in both acute and chronic
cases. False lumen thrombosis and induced aortic
remodelling by closure of the entry site may offer
the potential for avoiding long-term aortic rupture,
thus improving survival. However long-term out-
come data are still limited.
In the future, advanced laboratory tests, evidence-
based risk stratifying algorithms, biomarkers and
genetic analysis are likely to better define the clinical
profile of individual patients, in order to identify early
the benefit of different treatment strategies. In the
meantime, before improved understanding of the
pathogenesis of this lethal disease, the most realistic
approach continues to be careful patient monitoring
with timely imaging studies and optimal pharmaco-
logical therapy as basic instruments for preventing
dilation and risk of rupture.References
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